Product category:
Antibodies
News Release from: Chemicon International | Subject: Cellntec line
Edited by the Laboratorytalk Editorial
Team on 04 April 2006
Chemicon and Cellntec in sales and
marketing deal
Chemicon will now offer the Cellntec line of culture media for the expansion of human, mouse, and rat epithelial progenitor cells as part of its growing stem cell product line
Serologicals has announced that Chemicon International, its wholly-owned subsidiary, and Cellntec Advanced Cell Systems, have entered into an exclusive agreement to allow Chemicon worldwide distribution of the Cellntec line of products Under the terms of this multi-year agreement, Chemicon will now offer the Cellntec line of culture media for the expansion of human, mouse, and rat epithelial progenitor cells as part of its growing stem cell product line
This article was originally published on Laboratorytalk on 11 Jul 2001 at 8.00am (UK)
Related stories
Guinea-pig polyclonal antibody to nicastrin
Immunohistochemical analysis reveals that nicastrin is localised to neurons known to be affected by Alzheimer's; Chemicon announces its new guinea-pig polyclonal antibody
Agreement covers ReNcell neural stem cell lines
Chemicon International and ReNeuron have entered into an agreement to allow Chemicon to exclusively distribute two of ReNeuron's patented ReNcell neural stem cell lines worldwide for research purposes
By offering these products, Chemicon will provide researchers with greater access to the PCT (progenitor cell targeted) line of culture media from Cellntec.
These media allow the researcher to maintain and expand undifferentiated progenitor cells found in epithelial tissues.
Cellntec PCT products allow researchers to grow progenitor cells for research in dermatology, cancer, tissue regeneration and other areas of research.
"Chemicon is excited to collaborate with Cellntec in providing these products to the research marketplace" said Jeffrey Linton, president of Chemicon and Upstate, Serologicals' Research Segment companies.
"These products will expand our offering for researchers working with adult progenitor and stem cells, as well as in the specialized stem cell culture area of research." "We are delighted to have established this agreement with Chemicon," said Peter Girling, CEO of Cellntec.
"We believe that Chemicon's stem cell focus, and the complimentary fit of our products into their existing portfolio, will provide the ideal framework for bringing the benefits of our progenitor cell- targeted in vitro tools to researchers around the world." Chemicon International offers a broad range of research products, including specialty reagents, kits, antibodies, and custom products and services, to customers working in the areas of neuroscience, stem cell biology, cancer, and infectious disease research.
It is also a leading supplier of monoclonal antibodies, conjugates, antibody blends and molecular- based detection kits for use in diagnostic laboratories.
Chemicon focuses on basic and biomedical research, drug discovery, and diagnostics, allowing it to serve thousands of customers worldwide in the academic, clinical, biotechnology, and pharmaceutical sectors.
• Chemicon International: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
